Company / Working Capital
PAVmed Inc. Working Capital History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
-$12.3M
FY2025
5-year range
-$33.3M / $2.7M
FY2022-FY2025
Trend
+63.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital returned to growth in FY2025 after 2 years of decline, reaching -$12M.
Based on SEC 10-K filings.
-$12M in FY2025.
Improved from -$30M to -$12M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital increased 63.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.3M | +63.1% |
| FY2024 | -$33.3M | -12.1% |
| FY2023 | -$29.7M | -1188.7% |
| FY2022 | $2.7M | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026